Fierce Biotech: 2nd Drug Development Forum (EXL)
Fierce Biotech: 2nd Drug Development Forum (EXL)
Event on 2017-09-25 08:00:00
The FDA approved only 22 new drug candidates in 2016 — less than half of the prior year, and the lowest level since 2010. The IPO market has collapsed to its lowest level since 2009. In the face of this regulatory and financial uncertainty, biotech companies must increasingly rely on creative deal-making and the discovery of new indications for established products. But that requires an entirely new approach to partnerships and pipeline strategy, from the highest levels of biotech leadership.
The FierceBiotech 2nd Drug Development Forum is unequaled at drawing together the industry's executive decision-makers. Its purpose is to guide you towards new strategies throughout the entire life cycle – of both your product and your company.
This year's agenda features:
Over 75 expert speakers – nearly all at the VP level or C-suite
Four detailed learning tracks covering biotech partnerships for funding, clinical research, R&D outcomes, and data resources
Four in-depth workshops
Learning and networking opportunities with over 350 biotech industry leaders
Who Should Attend
This event is aimed at professionals in the pharmaceutical, biotech, medical device and venture capitalist fields responsible for:
Mergers and Acquisitions
Clinical Research/Clinical Development
Strategy/Product Strategy/Strategic Development
Clinical Trial Management
This event is also of interest to:
Supply Chain Professionals
Clinical Data Management Specialists
Business Development Specialists
Key subject areas
Mergers & acquisitions to strengthen your drug pipeline
Remote clinical monitoring and its impact on development speed
The art of the biotech deal: creating syndicates and driving value
Building relationships and networking with KOLs
Prioritizing late-stage development programs
Optimizing teamwork with CROs for drug development
Biopharma alliances with venture capitalists and academic researchers
Avoiding the riskiest pitfalls in early outsourced biotech operations
Team-based approaches to securing “breakthrough” designation from FDA
The greatest challenges in product valuation
Selecting ideal partners for emerging markets and orphan / specialty drugs
Adapting to FDA’s “Fast Track”
Engaging patients to avoid pitfalls in clinical research
Recognizing changes in biotech funding sources and trends
Vice President, Strategy and Investor Relations
MASS MEDICAL ANGELS
Senior Vice President, Head of Clinical Development
Big3Bio is the leading aggregator service for the top three life science hubs in the world: Boston, San Diego, and the San Francisco Bay Area. Big3Bio’s newsletters and additional channels provide complete, daily coverage of the news, events, jobs, and developments in these regions to the industry’s top professionals and executives.
CrowdReviews.com is a transparent online platform for determining which products and services are the best based on the opinion of the crowd. The crowd consists of Internet users who have experienced products and services firsthand and have an interest in letting other potential buyers their thoughts on their experience.
The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, education, research & development, and commercialization. The MLSC is charged with implementing a -billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences.
MEDtube is an innovative video education platform for health professionals. It allows sharing videos and other materials with a community of more than 110,000 users worldwide, as well as building e-learning courses. The videoteque is updated daily and now contains almost 15,000 videos.
PharmaLeaders.com is an online environment dedicated to enriching the careers of more than 200,000 life sciences professionals. With breaking news and informative content grouped into one of nine segmented channels, in-depth special reports, job and events postings, and so much more, industry executives, manufacturers, marketers and educators can count on PharmaLeaders for the tools they need to succeed in today’s competitive market environment.
pharmaphorum drives innovation within the pharmaceutical industry, by bringing together healthcare through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.
PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharma marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the ‘360’ in our title signifies the combination of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discover and analytical arenas.
Please contact the event manager Marilyn below for the following:
– Discounts for registering 5 or more participants.
– If you company requires a price quotation.
Event Manager Contact: marilyn.b.turner(at)nyeventslist.com
You can also contact us if you require a visa invitation letter, after ticket purchase.
We can also provide a certificate of completion for this event if required.
This Event Listing is Promoted by
New York Media Technologies LLC in association
with EXL Events Inc.
at Renaissance Boston Waterfront Hotel
606 Congress Street
Boston, United States